Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of the amino acids l-ornithine and l-aspartate. It is believed to reduce ammonia levels in the body by promoting its detoxification in the liver and peripheral tissues.
## Primary Indications
Treatment of latent and manifest hepatic encephalopathy (HE) associated with hyperammonemia.
## Adult Dosing
* **Initial Dose:** 5-10 grams (one to two sachets or vials) intravenously (IV) every 8-12 hours.
* **Maintenance Dose:** 5-10 grams (one to two sachets or vials) orally once to three times daily.
* The exact daily dose and frequency should be adjusted based on the severity of hepatic encephalopathy and individual patient response.
## Pediatric Dosing
The use of Hepamerz in pediatric patients is not well-established due to limited data. Dosing should be individualized under the guidance of a specialist.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, as the drug is metabolized and excreted by the body. However, close monitoring of patient response is crucial.
## Contraindications
* Hypersensitivity to l-ornithine, l-aspartate, or any component of the formulation.
* Severe renal insufficiency (creatinine clearance < 25 mL/min) is a relative contraindication due to potential accumulation of amino acids.
## Adverse Effects
* **Common:** Nausea, vomiting, abdominal discomfort, diarrhea.
* **Less Common:** Skin rash, pruritus.
* **Rare:** Dizziness, headache.
## Key Drug Interactions
No significant drug interactions have been widely reported. However, caution should be exercised when co-administering with other medications affecting ammonia levels or electrolyte balance.
## Monitoring
* **Clinical:** Monitor for improvement in symptoms of hepatic encephalopathy (e.g., confusion, asterixis).
* **Laboratory:** Periodic monitoring of ammonia levels, liver function tests, and renal function is recommended.
## Clinical Pearls
* Hepamerz is most effective in patients with hyperammonemia.
* The oral formulation can be dissolved in water or other beverages.
* For IV administration, dilute in a suitable infusion solution (e.g., 0.9% sodium chloride or 5% dextrose) and infuse slowly to minimize local irritation.
***
*Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and local protocols before administering any medication. Dosing and indications may vary.*
